Education
About Us
Working with TipRanks
Follow Us
OMFS - ETF AI Analysis
Top Page
Invesco Russell 2000 Dynamic Multifactor ETF (OMFS)
Rating:65Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown solid gains so far this year and in recent months, indicating positive momentum.
Top Holdings Showing Strength
Most of the largest positions, such as Compass, Dana, and Herbalife, have delivered strong year-to-date performance, helping support the fund’s returns.
Broad Sector Diversification
The fund spreads its investments across many sectors, including financials, industrials, health care, consumer cyclical, and technology, which helps reduce reliance on any single industry.
Negative Factors
High U.S. Concentration
With the vast majority of assets in U.S. companies, the ETF offers very limited international diversification and is heavily tied to the U.S. market.
Moderate Expense Ratio
The fund’s expense ratio is not especially low, meaning fees may be higher than some cheaper index ETFs and can slightly reduce net returns over time.
Exposure to Volatile Smaller Companies
Because the ETF focuses on smaller U.S. stocks, investors face higher potential price swings and company-specific risk compared with large-cap funds.
OMFS vs. SPDR S&P 500 ETF (SPY)
AUM274.47M
RegionNorth America
Expense Ratio0.39%
Beta0.90
IssuerInvesco
Inception DateNov 08, 2017
Dividend Yield0.74%
Asset ClassEquity
Index TrackedRussell 2000 Invesco Dynamic Multifactor Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume12,043
30 Day Avg. Volume12,771
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
56.65Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1672
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
OMFS Summary
OMFS is the Invesco Russell 2000 Dynamic Multifactor ETF, which follows the Russell 2000 Invesco Dynamic Multifactor Index. It focuses on smaller U.S. companies (small caps) across many sectors like financials, industrials, health care, and technology. The fund holds lesser-known but real operating businesses such as Herbalife and ViaSat, and it shifts its mix based on factors like value and quality. Someone might invest in OMFS to seek long-term growth and diversification beyond large, well-known stocks. A key risk is that small-cap stocks can be more volatile and can go up and down more sharply than the overall market.
How much will it cost me?The Invesco Russell 2000 Dynamic Multifactor ETF (OMFS) has an expense ratio of 0.39%, meaning you’ll pay $3.90 per year for every $1,000 invested. This is slightly higher than average for ETFs because it uses an actively managed multifactor strategy to adjust its portfolio dynamically, rather than passively tracking an index.
What would affect this ETF?The OMFS ETF, focused on U.S. small-cap companies, could benefit from economic growth and innovation in sectors like technology and health care, which are key components of its portfolio. However, it may face challenges from rising interest rates or economic slowdowns, which tend to impact smaller companies more significantly. Regulatory changes or sector-specific disruptions, particularly in financials and industrials, could also influence its performance.
OMFS Top 10 Holdings
OMFS is riding a wave of small-cap momentum, with names like Compass, Dana, and Constellium doing much of the heavy lifting as their shares have been steadily rising on improving outlooks and solid technical trends. Herbalife has also been a surprising spark, adding extra fuel with strong recent gains despite its debt overhang. On the flip side, D-Wave Quantum is dragging a bit, with more mixed trading as investors wrestle with its big ambitions and weak finances. Overall, the fund is broadly spread across U.S. sectors, without a single industry dominating the story.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Terex | 0.45% | $1.23M | $7.89B | 52.09% | 71 Outperform | |
| Dana Incorporated | 0.42% | $1.15M | $3.90B | 104.22% | 58 Neutral | |
| Compass | 0.41% | $1.14M | $7.47B | 31.27% | 61 Neutral | |
| Constellium | 0.34% | $939.94K | $3.21B | 149.36% | 64 Neutral | |
| ACM Research | 0.31% | $854.97K | $4.21B | 172.67% | 72 Outperform | |
| Peabody Energy Comm | 0.31% | $851.76K | $4.19B | 112.52% | 61 Neutral | |
| Praxis Precision Medicines | 0.29% | $805.33K | $8.69B | 249.51% | 58 Neutral | |
| Herbalife | 0.29% | $785.80K | $1.64B | 182.92% | 71 Outperform | |
| ViaSat | 0.28% | $772.99K | $6.64B | 432.72% | 56 Neutral | |
| The Andersons | 0.27% | $743.17K | $2.34B | 70.23% | 71 Outperform |
OMFS Technical Analysis
Positive
―
Price Trends
46.44
Positive
44.95
Positive
42.77
Positive
Market Momentum
0.47
Positive
55.51
Neutral
55.54
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For OMFS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 47.66, equal to the 50-day MA of 46.44, and equal to the 200-day MA of 42.77, indicating a bullish trend. The MACD of 0.47 indicates Positive momentum. The RSI at 55.51 is Neutral, neither overbought nor oversold. The STOCH value of 55.54 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for OMFS.
OMFS Peer Comparison
Comparison Results
Performance Comparison
OMFS
Invesco Russell 2000 Dynamic Multifactor ETF
47.89
7.03
17.21%
OUSM
OShares U.S. Small-Cap Quality Dividend ETF
―
―
―
GSSC
Goldman Sachs Activebeta U.S. Small Cap Equity ETF
―
―
―
JHSC
John Hancock Multifactor Small Cap ETF
―
―
―
SMDV
ProShares Russell 2000 Dividend Growers ETF
―
―
―
BBSC
JPMorgan BetaBuilders U.S. Small Cap Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents